Teva Provides Updated 2012 Non-GAAP Financial Outlook; Updated 2012 Non-GAAP Diluted EPS of $5.30 to $5.40 - StreetInsider.com

COPAXONE® of $3.8 billion-- TREANDA® of $580 million-- Women’s Health products of $500 million-- ProAir® HFA of $430 million-- QVAR® of $350 million-- PROVIGIL® of $420 million-- AZILECT® of $340 million-- NUVIGIL® of $300 million -- OTC net sales ...

Teva Pharma (TEVA) Sees Weaker FY12 Sales, EPS - StreetInsider.com

Brand product net sales of approximately $8.0 billion including estimated global net sales of the following products: COPAXONE of $3.8 billion-- TREANDA® of $580 million-- Women’s Health products of $500 million-- ProAir® HFA of $430 million-- QVAR ...

Prep Zone: Cary-Grove hurdler Wollney jumps at offer from Miami of Ohio - Mchenry County Sports.com

Cary-Grove’s Kathie Wollney was in no hurry to make her college choice. First of all, the senior hurdler had to figure out if she wanted to compete in track and field or just go be a student. Next came the process of finding the proper fit for ...

Teva Reports First Quarter 2012 Results - Business Wire

Respiratory products revenues were up 4% to $190 million, driven primarily by higher global sales of Qvar® that reached $63 million this quarter, partially off-set by lower sales of ProAir® due to the renegotiation of the distribution sales agreements in ...

Medicis Outshines in 1Q - Zacks.com

Revenues from other non-dermatological products shot up 108.5% during the quarter to $19.2 million, driven by higher sales of Maxair Autohaler in the U.S. and Qvar in Canada (both acquired in fourth quarter of 2011). The non-dermatological products ...

Medicis Outshines in 1Q - Analyst Blog - Boston Globe

Revenues from other non-dermatological products shot up 108.5% during the quarter to $19.2 million, driven by higher sales of Maxair Autohaler in the U.S. and Qvar in Canada (both acquired in fourth quarter of 2011). The non-dermatological ...

Medicis Reports First Quarter 2012 Financial Results - msnbc.com

The Company acquired ZYCLARA and ALDARA in the fourth quarter of 2011. The Company acquired the MAXAIR AUTOHALER and QVAR (in Canada only) in the fourth quarter of 2011. The Medicis Other Non-Dermatological Products category includes primarily A ...